US 12,214,024 B2Granted

Use of APC analogue for wound healing

AssigneeZZ Biotech LLC

InventorsMeilang Xue, Christopher John Jackson

Life of this patent

Estimating the term…

Abstract

The invention relates to wound repair and healing, particularly to dermal or cutaneous wounds including but not limited to acute and chronic wounds, burns and ulcers.

Claims17

Dependent claims

A method for accelerating healing of a dermal wound including the step of directly contacting a dermal wound with an effective amount of 3K3A-APC, thereby accelerating the healing of the dermal wound.

Dependencies are inferred from the claim text.

Facts

Application: 16/569,975Filed 13 Sep 2019 · continuation
Priority: AU 201490139716 Apr 2014
Published: US 2020/0000890 A12 Jan 2020
Granted: 4 Feb 2025
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 38/4866
Serine endopeptidases: protein C
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61L 26/0066
Use of materials characterised by their function or physical properties: medicaments; Biocides

Family

PCT/AU2015/050177Parent of this continuation · filed 16 Apr 2015
Application15/897,801Parent of this continuation · filed 15 Feb 2018
US 2020/0000890 A1Pre-grant publication · published 2 Jan 2020
Application15/304,433Parent of this continuation
US 2017/0035862 A1Published application
US 2018/0243383 A1Published application
US 12,214,024 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results